Our team assesses biomarkers, goals, and designs protocolsNAD+ via injections/IVs, 5-Amino-1MQ as capsules/injections
What the new mechanism is: GLP-1 : appetite regulation, improved glucose control GIP : incretin effects that may augment metabolic benefits Glucagon receptor activity : potentially influences energy expenditure and fat metabolism (while requiring careful balancing of tolerability and metabolic effects) What results look like (so far): Phase 2 (48 weeks) published in NEJM showed substantial mean weight reductions (with higher doses showing very large effects)
Protein oxidation: Protein carbonyl groups serve as reliable biomarkers of protein oxidation
Heat Intolerance Another important side effect is that of heat intolerance
Tartrato de L-Carnitina, almidn de maz (vehculo), antihumectante de fosfato triclcico y cpsula (gelatina, agua purificada, colorantes de dixido de titanio, rojo 40, azorrubina y amarillo de quinolena)